Similar to This
Previous

Paid articlePaywall Beyond statins, one drug lowered heart attack risk by 20%: A new study could help doctors figure out what medicine to prescribe for cholesterol when statins ...
statnews.com/2026/11/05/repatha-vs-zetia-cholesterol-study-heart-attack-risk/

Blood pressure medication recalled nationwide. See the affected drug
usatoday.com/story/money/consumer-protection/recalls-alerts/2026/11/02/blood-pressure-medication-recalled/92563231007/

Trump administration will allow pharmacies to make popular peptides: The Department of Health and Human Services will let small compounding pharmacies make six ...
npr.org/2026/10/28/nx-s1-6021030/peptides-compounding-enforcement
Paid articlePaywall Disc Medicine Stock Has Its Best Day Since 2022 as Drug Trial Revives FDA Approval Hopes
barrons.com/articles/disc-medicine-stock-price-bitopertin-fda-af6b9880
Why Big Pharma is betting on longevity drugs: Inside the conference where FDA officials, Eli Lilly, Pfizer, and biotech leaders mapped out the future of ...
businessinsider.com/why-big-pharma-betting-longevity-drugs-2026-10

Medicine shortages grow in Iran as US tightens sanctions, blockade: Many Iranians cannot access or afford life-saving drugs, but authorities say pharmaceutical ...
aljazeera.com/news/2026/9/9/medicine-shortages-grow-in-iran-as-us-tightens-sanctions-blockade

The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remains
statnews.com/2026/09/04/clozapine-children-schizophrenia-neutrophil-fda-monitoring/

Tavneos: Rare disease drug recalled in Republic of Ireland: Tavneos is used to treat adults with severe and rare autoimmune diseases which cause inflammation of ...
bbc.com/news/articles/c5ye1lz0l85o

Argenx Breaks Out On Another Multibillion-Dollar Opportunity For Vyvgart: Argenx stock surged Monday after its blockbuster autoimmune drug, Vyvgart ...
investors.com/news/technology/argenx-stock-vyvgart-imnm-dm-treatment/

Paid articlePaywall California Supreme Court sides with Gilead in ‘duty’ to innovate case: Advocates argued Gilead was negligent for slow-walking development of an HIV medicine that ...
statnews.com/pharmalot/2026/08/03/california-supreme-court-sides-with-gilead-in-duty-to-innovate-case/

We’re beating heart disease: The FDA-approved pill enlicitide lowers LDL cholesterol by nearly 60 percent, marking the latest advance in medicine’s decades-long ...
vox.com/future-perfect/496672/heart-disease-cholesterol-ldl-death-health

Paid articlePaywall Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more
statnews.com/pharmalot/2026/07/27/fda-panel-peptide-votes-amgen-fights-tavneos-withdrawal/

EU regulator backs revoking Amgen's right to sell rare-disease drug: Europe's drug regulator on Friday recommended revoking the marketing authorization for ...
reuters.com/business/healthcare-pharmaceuticals/ema-recommends-revoking-marketing-authorisation-amgens-rare-disease-drug-2026-06-26/

Drugmaker Apotex Health seeks biggest Canada IPO since 2021: Canadian generic drug manufacturer Apotex Health Corp. and its shareholders may raise as much as $1 ...
financialpost.com/investing/drugmaker-apotex-health-seeks-ipo
Paid articlePaywall Amgen Drug Gets New Warnings in Japan After Patient Deaths: Japanese drugmaker that sells rare-disease medicine Tavneos says new patients will be able to get the ...
wsj.com/health/pharma/amgen-drug-gets-new-warnings-in-japan-after-patient-deaths-e903b551

Amgen's rare disease drug linked to deaths, liver injuries in Japan, Kissei reports
reuters.com/business/healthcare-pharmaceuticals/amgens-rare-disease-drug-linked-deaths-liver-injuries-japan-wsj-reports-2026-05-15/

Paid articlePaywall FDA approves Denali Therapeutics drug for Hunter syndrome: The decision is notable in part because it follows a string of FDA rejections or calls for additional ...
statnews.com/2026/03/25/denali-therapeutics-hunter-syndrome-rare-disease/
Next